Black Friday: Superpowermembership now $179$199

Nonapeptide-1: What the Brightening Peptide Can Do for Dark Spots

Published

Last updated

Key takeaway:

Nonapeptide-1, sold as Melanostatine-5, is a nine-amino-acid peptide designed to block alpha-MSH, the signal that prompts pigment cells to make melanin. Cell research and a 2024 delivery study support that mechanism, but clinical trials on human pigmentation are lacking. Realistic expectations are modest fading of mild discoloration over two to three months. It works best as a gentle adjunct alongside daily sunscreen and other brightening actives.

Read more →

At a glance

  • Nonapeptide-1 (sold as Melanostatine-5) is a brightening peptide aimed at dark spots and uneven tone.
  • It works upstream of pigment, acting as an antagonist at the receptor that the hormone alpha-MSH uses to switch on melanin production.
  • In laboratory studies it serves as a reference MSH-blocking agent and has been shown to interfere with melanin transfer.
  • Standalone clinical trials on human pigmentation are lacking, so it is best seen as a gentle adjunct rather than a primary spot treatment.
  • Evidence strength: Limited, based on cell studies and delivery research rather than clinical trials.

What is nonapeptide-1?

Nonapeptide-1, trade name Melanostatine-5, is a nine-amino-acid peptide developed to reduce excess pigment. Its design is based on blocking alpha-melanocyte-stimulating hormone (alpha-MSH), the signal that prompts pigment cells to make melanin. It appears in brightening serums and creams positioned as a gentler alternative to acids and hydroquinone.

What skin type is nonapeptide-1 best for?

It is aimed at people with hyperpigmentation, dark spots, or uneven tone who want a mild option, and because it is a peptide rather than an acid it suits most skin types, including sensitive skin. People with stubborn melasma or deep pigmentation usually need stronger, better-proven treatments.

What does nonapeptide-1 do?

It targets an early step in pigment formation. Alpha-MSH binds the melanocortin-1 receptor on pigment cells to trigger melanin synthesis, and nonapeptide-1 is designed to act as an antagonist at that pathway. In a 2022 melanogenesis study, nonapeptide-1 acetate was used as a known alpha-MSH antagonist for comparison, and a 2024 study that attached nonapeptide-1 to a delivery particle described its melanin-transfer-interfering properties and reduced melanin in treated skin. Both lines of work support the mechanism without being standalone clinical trials.

How do you know if nonapeptide-1 can help your skin?

It is reasonable to try if you want a gentle brightening ingredient to support other measures, and realistic expectations are modest fading of mild discoloration over two to three months. For established melasma or dark spots that matter to you, dermatologist-guided options have much stronger evidence.

How do you use nonapeptide-1?

Apply once or twice daily to clean skin in a serum or moisturizer. The single most important partner for any brightening routine is broad-spectrum sunscreen every morning, because sun exposure drives the pigment you are trying to reduce. Give it consistent use over weeks.

What should you use with nonapeptide-1?

It combines well with other brightening actives such as niacinamide and vitamin C, and with hydrating ingredients like hyaluronic acid. Daily sunscreen is essential alongside it. Because its own evidence is limited, it works best as one part of a tone-evening routine rather than the sole treatment.

Evidence strength

Limited: The mechanism, blocking alpha-MSH signaling to pigment cells, is biologically sound and is supported by cell-based melanogenesis research and by delivery studies showing reduced melanin. What is missing is independent clinical trials measuring the peptide's effect on hyperpigmentation in people, so its real-world brightening power is not well quantified. It is a reasonable, low-risk adjunct rather than a proven primary treatment.

References

  1. Chen J, Li H, Liang B, Zhu H. Effects of tea polyphenols on UVA-induced melanogenesis via inhibition of α-MSH-MC1R signalling pathway. Advances in Dermatology and Allergology. 2022;39(2):327-335. doi:10.5114/ada.2022.115890
  2. Huang ZJ, Zhou XH, Wen WQ, et al. Enhanced skin benefits of EGCG loaded in nonapeptide-1-conjugated mesoporous silica nanoparticles to reverse skin photoaging. International Journal of Pharmaceutics. 2024;665:124690. doi:10.1016/j.ijpharm.2024.124690

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Biological age 32 — a Superpower member portraitA health system built around you — test, understand, optimize100+ biomarkers across 2 blood drawsWhat to expect with Superpower — week 1 to month 3Better than the status quo — Superpower vs the old way60% of members found something a doctor missed — member survey
Daniel OSuperpower memberDavid LSuperpower memberRachel DSuperpower memberCamelia VSuperpower member

64,000+ members

Superpower health membership

Find early signs of 1,000+ conditions from a single blood draw - then act on what you find.

$199

$179

/year*

Black Friday: $20 off

100+ biomarkers from a single blood draw

Personalized plan that turns results into action

Superpower AI and on-demand care team

Results in 10 days or less

2,000+ labs nationwide

Yearly membership$0.49 / dayHSA/FSA eligible

*Pricing may vary for members in New York and New Jersey

What we test

TestosteroneFree T4Vitamin DApoBHbA1cThyroid (TSH)hs-CRPFerritinCortisolFasting insulin

60%

found something a doctor missed

93%

rated it more useful than their checkup

77%

found something new in their results

Superpower member survey, 90 days post action plan (n=143).

How does the Superpower membership work?

We test 100+ biomarkers from a single blood draw each year. Your baseline test paints a comprehensive picture of your health, and your dashboard shows what’s working, what needs attention, and what to do next. Superpower AI and your care team help you take action across lifestyle, supplements, and treatments.

Can I cancel anytime?

Yes. You can cancel anytime, no fees. Your membership stays active through the end of your paid year.

How often should I test?

Your membership includes two blood tests per year: one to establish your baseline, and one to see whether your plan improved biomarkers that were out of range or not yet optimized. You can add other diagnostics anytime through the app or with help from your care team.

When will I get my results?

Book your draw at any of 2,000+ partner labs. Results are typically ready in about a week and land in the Superpower app.